Morning Overview on MSN
The FDA approved a lower-dose contrast agent to cut patients’ exposure during MRI scans
Patients who need repeated MRI scans with contrast dye could soon receive a fraction of the gadolinium they currently get.
Gadolinium-enhanced delayed inner ear magnetic resonance imaging (MRI) improves diagnostic accuracy for Meniere disease (MD) and delayed endolymphatic hydrops (DEH), according to a study published ...
Gadolinium-enhanced magnetic resonance imaging (MRI) of the inner ear can help differentiate Meniere disease (MD) from vestibular migraine (VM), according to a study published online June 26 in The ...
January 2, 2007 — The US Food and Drug Administration (FDA) warned healthcare professionals last week about additional reports of nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy ...
Simulations reveal details about the magnetic interactions between gadolinium contrast agents used in MRI scans and their environment. You can keep your best guesses. Engineers at Rice University's ...
Gadolinium-based contrast agents are integral to modern magnetic resonance imaging, enhancing diagnostic accuracy by shortening proton relaxation times and improving tissue contrast. Gadolinium(III) ...
Contrast agents are often used in diagnostic technologies like MRIs. There are many different types of contrast agents, which can make tissues much easier to see against the background fluids of the ...
An unexpected discovery surprised a scientist at the Max Planck Institute for Intelligent Systems in Stuttgart: Nanometer-sized diamond particles, which were intended for a completely different ...
University of New Mexico researchers studying the health risks posed by gadolinium, a toxic rare earth metal used in MRI scans, have found that oxalic acid, a molecule found in many foods, can ...
Physicians routinely prescribe an infusion containing gadolinium to enhance MRI scans, but there is evidence that nanoparticles of the toxic rare earth metal infiltrate kidney cells, sometimes ...
Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results